Moderna is set to disclose further details on its MRNA-based cancer vaccine initiative next month. The upcoming data release represents a pivotal step in the company’s efforts to demonstrate the viability of its technology in the oncology sector.
Florida health officials confirmed the state's first dengue-related death this year, while locally acquired cases hit their highest weekly total since 2023.
A new FDA study of 14.8 million seniors confirms RSV vaccines reduce hospitalization and death by 80%, mirroring clinical trial results despite…
Partners of women are being asked to try a MenoVest simulation at the Menopaus'ull Support Network event in Hull on 17 October.
My mom is in a clinical trial for this. Fingers crossed the data looks promising.
Moderna’s pivot to oncology is bold. If this works, it changes everything for cancer treatment.
I’m skeptical about tumor heterogeneity. Will one vaccine truly work for everyone? Doubtful.
Finally, some tangible proof that mRNA works beyond viruses. Crossing fingers for the results.